Share on StockTwits

OptimizeRx Co.(NDA) (NASDAQ:OPRX) CFO Douglas P. Baker acquired 10,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $1.50 per share, with a total value of $15,000.00. Following the completion of the transaction, the chief financial officer now directly owns 10,000 shares of the company’s stock, valued at approximately $15,000. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of OptimizeRx Co.(NDA) in a research note on Friday, April 4th. They now have a $4.00 price target on the stock.

OptimizeRx Co (NASDAQ:OPRX) opened at 1.48 on Friday. OptimizeRx Co has a 52 week low of $0.86 and a 52 week high of $2.12. The stock has a 50-day moving average of $1.63 and a 200-day moving average of $1.65. The company’s market cap is $34.9 million.

OptimizeRx Co.(NDA) (NASDAQ:OPRX) last posted its quarterly earnings results on Tuesday, May 20th. The company reported ($0.04) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.01 by $0.05.

OptimizeRx Corporation provides platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.